You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Antidepressant Therapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Major Depressive Disorder With Anhedonia and Inadequate Response

Not yet recruiting
  • Depressive Disorder, Major
  • No Intervention
  • (no location specified)
Apr 24, 2023

Treatment Resistant Depression, MDD, Analgesia Trial in Brooklyn (VTS-K)

Recruiting
  • Treatment Resistant Depression
  • +12 more
  • Brooklyn, New York
    Maimonides Medical Center
Dec 12, 2022

Depression Trial in Münchenbuchsee, Solothurn (Pharmacist-guided pharmacogenetic (PGx) testing for antidepressant selection and

Recruiting
  • Depression
  • Pharmacist-guided pharmacogenetic (PGx) testing for antidepressant selection and dosing
  • Standard care antidepressant selection and dosing
  • Münchenbuchsee, Bern, Switzerland
  • +1 more
Dec 14, 2021

Electroconvulsive Therapy

Not yet recruiting
  • Depressive Disorder, Major
  • Electroconvulsive therapy
  • (no location specified)
Nov 18, 2022

Renormalization Associated With Antidepressant Transcranial

Recruiting
  • Major Depressive Disorder
  • Neuroimaging with Magnetic Resonance Imaging (MRI)
  • Charleston, South Carolina
    Medical University of South Carolina
Sep 15, 2023

Depressive Disorder, Major Trial in France (Digital Assessment on mobile)

Recruiting
  • Depressive Disorder, Major
  • Digital Assessment on mobile
  • Cholet, France
  • +11 more
Mar 17, 2022

Depression Trial in New York (Standard antidepressant therapy (SADT), Motivational antidepressant therapy (MADT))

Completed
Has Results
  • Depression
  • Standard antidepressant therapy (SADT)
  • Motivational antidepressant therapy (MADT)
  • New York, New York
    New York State Psychiatric Institute, 1051 Riverside Drive
Apr 29, 2021

MDD Trial in Florence (SUMOR, Placebo)

Recruiting
  • Major Depressive Disorder
  • SUMOR
  • Placebo
  • Florence, Italy
    Azienda Ospedaliero Universitaria Careggi
Oct 14, 2021

Depression, Anxiety, Generalized Anxiety Disorder Trial in Tampa (DNA-guided choice of therapy, Clinical management)

Active, not recruiting
  • Depression
  • +5 more
  • DNA-guided choice of therapy
  • Clinical management
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Mar 23, 2022

MDDs Trial in Tianjin (N-acetylcysteine, comparator of N-acetylcysteine)

Recruiting
  • Major Depressive Disorders
  • Tianjin, Tianjin, China
    Tianjin Anding Hospital
Sep 21, 2022

Treatment Resistant Depression Trial in United States (MK-1942, Placebo)

Recruiting
  • Treatment Resistant Depression
  • Birmingham, Alabama
  • +30 more
Aug 8, 2022

Depressive Disorder, Major Trial in United States (JNJ-42847922, Placebo Matching to JNJ-42847922, Quetiapine XR)

Completed
Has Results
  • Depressive Disorder, Major
  • Phoenix, Arizona
  • +49 more
Jul 20, 2022

Depressive Symptoms Trial in Logan (LifeStories)

Active, not recruiting
  • Depressive Symptoms
  • LifeStories
  • Logan, Utah
    Utah State University
Dec 1, 2021

Depressive Disorder, Major, Obesity Trial in Germany (Simvastatin 40mg, Placebo oral tablet)

Recruiting
  • Depressive Disorder, Major
  • Obesity
  • Simvastatin 40mg
  • Placebo oral tablet
  • Berlin, Germany
  • +8 more
Mar 9, 2022

Depression Trial (Cognitive-Behavioural Therapy, Antidepressant medication)

Not yet recruiting
  • Depression
  • Cognitive-Behavioural Therapy
  • Antidepressant medication
  • (no location specified)
Aug 4, 2021

Depression Trial in United States (Esketamine, Cognitive Behavioral Therapy (CBT), Antidepressant)

Not yet recruiting
  • Depression
  • New Haven, Connecticut
  • +5 more
Aug 17, 2022

Depressive Disorder, Major, Anhedonia Trial in Worldwide (Aticrapant, Placebo)

Recruiting
  • Depressive Disorder, Major
  • Anhedonia
  • Phoenix, Arizona
  • +72 more
Jul 10, 2022

Depressive Disorder, Major Trial in Worldwide (Seltorexant, Placebo)

Terminated
  • Depressive Disorder, Major
  • Phoenix, Arizona
  • +79 more
Oct 3, 2022

MDD Trial in United States (Antidepressant + SPD489 (lisdexamfetamine dimesylate), Antidepressant + )

Completed
Has Results
  • Major Depressive Disorder
  • Antidepressant + SPD489 (lisdexamfetamine dimesylate)
  • Antidepressant + placebo
  • Newport Beach, California
  • +14 more
Jun 8, 2021

Depressive Disorder, Hormone Disturbance Trial in Strasbourg, Rouffach (Metyrapone)

Recruiting
  • Depressive Disorder
  • Hormone Disturbance
  • Strasbourg, Bas Rhin, France
  • +1 more
Sep 8, 2020

Epilepsy Trial in Shanghai (psychology therapy)

Active, not recruiting
  • Epilepsy
  • psychology therapy
  • Shanghai, Shanghai, China
    Department of Neurology, Zhongshan Hospital, Fudan University, S
Dec 19, 2021

MDD Trial in Berlin (electroconvulsive therapy, Antidepressant)

Active, not recruiting
  • Major Depressive Disorder
  • Berlin, Germany
    Charité
Aug 2, 2021

Depression, MDD, Dysthymic Disorder Trial in Indianapolis (behavioral, drug, other)

Completed
Has Results
  • Depression
  • +7 more
  • Beating the Blues (BtB)
  • +3 more
  • Indianapolis, Indiana
    IUPUI Department of Psychology
Aug 30, 2021

MDD Trial in Hod Hasharon (Placebo, Ketamine (1st phase), Ketamine (2st phase))

Completed
  • Major Depressive Disorder
  • Placebo
  • +2 more
  • Hod Hasharon, Israel
    Shalvata MHC
Oct 27, 2020

Depression, MDD, Dysthymic Disorder Trial in Indianapolis (behavioral, drug, other)

Recruiting
  • Depression
  • +6 more
  • Good Days Ahead (GDA)
  • +3 more
  • Indianapolis, Indiana
    IUPUI Department of Psychology
Jan 18, 2022